No overview information available.
No background information available.
用于各种原因的蛋白质缺乏和衰弱患者以及对一般蛋白质消化吸收障碍的病例。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H45021238 | 口服溶液剂 | N/A | 10ml;30ml;100ml | Chemical Drug | Approved | 2020/05/18 | Domestic | ||
国药准字H45021316 | 散剂 | N/A | 5g、10g、15g | Chemical Drug | Approved | 2020/05/18 | Domestic | ||
国药准字H31022678 | N/A | N/A | 原料药 | Chemical Drug | Approved | 2003/01/29 | Domestic | ||
国药准字H35021453 | 注射剂 | N/A | 500ml:25g(水解蛋白) | Chemical Drug | Approved | 2020/08/04 | Domestic | ||
国药准字H22026405 | 注射剂 | N/A | 500ml:25g(水解蛋白) | Chemical Drug | Approved | 2022/12/07 | Domestic | ||
国药准字H22025908 | N/A | N/A | 500ml:25g | Chemical Drug | Approved | 2003/05/31 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
364753 | Active | 2021/05/06 | Protein hydrolysate | ||
387578 | Active | 2022/04/27 | Protein hydrolysate |